Application of metabolic marker in atherosclerotic cerebral infarction
A technology of atherosclerosis and metabolites, applied in the field of biomedicine to achieve the effect of improving the quality of life
Image
Examples
Embodiment
[0038] Example Screening and efficacy judgment of metabolites related to atherosclerotic cerebral infarction
[0039] 1. Sample collection
[0040] Blood samples were collected from 21 patients with atherosclerotic cerebral infarction and 21 patients with atherosclerosis.
[0041] Atherosclerotic cerebral infarction group inclusion criteria:
[0042] 1) The subjects have signed the informed consent
[0043] 2) Meet the diagnostic criteria for acute cerebral infarction in the "Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke in China (2014 Edition)".
[0044] 3) The etiological type is atherosclerotic cerebral infarction.
[0045] 4) Age 18-65 years old.
[0046] 5) BMI 18.5-23.9kg / m 2 .
[0047] 6) Blood routine: red blood cell count, MCHC, hemoglobin, white blood cell count, lymphocyte count, neutrophil count, and monocyte count were within the normal range.
[0048] 7) TG, TC, HDL-C, LDL-C, blood sugar, glycosylated hemoglobin are within the normal ...
PUM
| Property | Measurement | Unit |
|---|---|---|
| Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- IPC
- G01N30/02; G01N30/90; G01N30/88; G01N24/08; G01N21/41; G01N21/33; G01N21/3577; G01N21/359; G01N27/327; G01N23/00; G01N27/62; G01N27/64; G01N30/72
- CPC
- G01N21/33; G01N21/3577; G01N21/359; G01N21/41; G01N23/00; G01N24/082; G01N27/327; G01N27/62
- Inventors
- å¼ ç¥¥å»º; å¼ åŸ¹åŸ¹



